Residents' Meeting

The Residents' Meeting is a one-and-a-half-day program that focuses on educating dermatology residents about recent advances in treatments and the management of psoriasis and psoriatic arthritis. The 2023 Residents' Meeting will be held in Washington, D.C., on Saturday, October 7, and Sunday, October 8.

What you can expect:

  • A one-and-a-half-day program providing a comprehensive psoriatic disease curriculum for dermatology residents
  • Evidence-based sessions presented by expert leaders in the field of psoriasis and psoriatic arthritis
  • Detailed overview of the clinical, medical, psychosocial, and economic impact of psoriasis and its management
  • Review of recent advances in the treatment of psoriasis and its associated comorbid disease states
  • Explore the diagnosis and management of psoriatic disease in skin of color and special patient populations
  • Examine strategies to alleviate the cost and barriers associated with psoriatic disease treatment options
  • Opportunities for residents to network with each other, industry partners, and leading academic dermatologists from various practice settings across the U.S.

The Residents' Meeting, one of our biggest and best-attended continuing medical education events, was founded in 1999 by Mark G. Lebwohl, M.D., of the Icahn School of Medicine at Mount Sinai, and chair emeritus of the NPF medical board. Our co-chairs for the 2023 Residents' Meeting are Brad P. Glick, D.O., MPH, FAAD, and Samuel Hwang M.D., Ph.D.

This 2023 Dermatology Residents and Rheumatology Fellows Meeting on Psoriatic Disease is provided by the National Psoriasis Foundation.  It is supported by educational grants from Janssen Biotech, Inc. and Pfizer Inc. and sponsored by NPF's corporate members.  It is also supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percentage funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Applications Are Now Closed

Questions about your application? Email us at medicalaffairs@psoriasis.org.

Learn about Travel and Lodging Information.

Get to Know the Chairs

Brad P. Glick, D.O., MPH, FAAD

Clinical Assistant Professor of Dermatology, Florida International University, Herbert Wertheim College of Medicine
Director of the Dermatology Residency Program, Larkin Community Hospital Palm Springs

Dr. Glick graduated from Emory University with a B.A. in chemistry and received his MPH from The Emory University School of Public Health. He earned his medical D.O. degree with honors at Nova Southeastern University. His internship in Internal Medicine was performed at South Broward Hospital and his residency in Family Medicine was performed at Wellington Regional Medical Center and the Palm Beach County Public Health Unit, West Palm Beach, Florida. Dr. Glick’s Dermatology residency training was performed at the Greater Miami Skin and Laser Center at Mount Sinai Medical Center, Miami Beach, Florida where he earned certificates in Dermatologic, Mohs Micrographic, and Laser Surgery.  

 
Brad Glick

Samuel T. Hwang, M.D., Ph.D.

Professor and Chair of Dermatology, University of California Davis

Dr. Hwang is a board-certified dermatologist with extensive training as a physician scientist. He has strong clinical and basic science interest in immunological diseases of the skin, including psoriasis, and in the biology of skin cancers, including melanoma and cutaneous T cell lymphoma. Starting as an Investigator and then Senior Investigator at NIH, Dr. Hwang has had over 15 years of experience in the field of leukocyte and cancer cell trafficking and has had a long-standing interest in the role of chemokine receptors, including CCR6 and CXCR4 in immune cells as well as cancer cells.

 
Sam Hwang

Sponsors

AbbvieAmgen LogoLogo of Arcutis Biotherapeutics.Boehringer Ingelheim logo.Bristol Meyers Squibb LogoPrimus Pharmaceuticals logoSun Pharma LogoUCB  logo with slogan 'Inspired by patients. Driven by science.'

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logoTwill Care logo

Copyright © 1996-2023 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.